Nash Huw M. 4
4 · Stoke Therapeutics, Inc. · Filed May 22, 2024
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Sale
Common Stock
2024-05-20$15.39/sh−50,000$769,500→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-20−50,000→ 46,000 totalExercise: $0.40Exp: 2026-02-11→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2024-05-20$0.40/sh+50,000$20,000→ 50,000 total
Footnotes (3)
- [F1]The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested.